It has a direct relaxing effect on vascular smooth muscle, reducing peripheral resistance and lowering blood pressure. It has an antispasmodic effect on gastrointestinal smooth muscle.

It has a direct relaxing effect on vascular smooth muscle, reducing peripheral resistance and lowering blood pressure. It has an antispasmodic effect on gastrointestinal smooth muscle.

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

Adrenal cortical hormones have anti-inflammatory and anti-allergic effects, can inhibit the proliferation of connective tissue, reduce the permeability of capillary walls and cell membranes, reduce inflammatory exudate, and inhibit the formation and release of histamine and other toxic substances.

Adrenal cortex hormone drugs. This product has anti-inflammatory and anti-allergic effects, can inhibit the proliferation of connective tissue, reduce the permeability of capillary walls and cell membranes, reduce inflammatory exudate, and inhibit the formation and release of histamine and other toxic substances.

Adrenal cortex hormone drugs. This product has anti-inflammatory and anti-allergic effects, can inhibit the proliferation of connective tissue, reduce the permeability of capillary walls and cell membranes, reduce inflammatory exudate, and inhibit the formation and release of histamine and other toxic substances.

The main function of CDCA is to reduce the saturation of cholesterol in bile. After taking CDCA for most patients (when CDCA accounts for 70% of bile salts in bile), lipids return to the micelle state and cholesterol is in an unsaturated state, thereby dissolving and falling off the cholesterol in the stones. Large doses of CDCA (10-15 mg/kg per day) can inhibit the synthesis of cholesterol and increase the secretion of bile in patients with cholelithiasis, but the secretion of bile salts and phospholipids remains unchanged.